Coherus BioSciences, Inc.CHRS

Market cap

$236.09M

P/E ratio

	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Net revenue	-	-	-	-	-	356	476	327	211
Cost of goods sold	-	-	-	-	-	-	38	58	70
Research and development	78	213	254	162	110	94	143	363	199
Selling, general and administrative	-	-	-	-	94	137	139	170	198
Total costs and expenses	-	-	-	-	-	-	320	590	468
(Loss) income from operations	-65	-219	-116	-232	-204	108	156	-264	-257
Interest expense	4	0	8	10	10	18	21	23	32
Loss on debt extinguishment	2	-	-	-	-	-	-	-	-6
Other income (expense), net	-19	-5	-4	3	5	3	1	-0	4
(Loss) income before income taxes	-	-	-	-	-	93	136	-287	-292
Income tax provision	-	-	-	-	-	3	4	-	-
Net (loss) income	-87	-223	-127	-238	-209	90	132	-287	-292
Earnings Per Share Basic	-	-	-	-	-	1.29	1.85	-3.81	-3.76
Earnings Per Share Diluted	-	-	-	-	-	1.23	1.62	-3.81	-3.76